Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.75M$2.75Mderived−4.9% vs Q4 2017 Net Income$52.05K$52.05KderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$79,204N/M Operating Cash Flowderived$22,802−81.9% Free Cash Flowderived-$4,344N/M Margins · derivedOperating margin2.9%+7.2 pt vs Q4 2017
Net margin1.9%+7.4 pt vs Q4 2017
ended Jun 30, 2018 · filed Sep 28, 2018 · 90 d after period end